Tadataka “Tachi” Yamada KBE

MD, BA - (Age 72)
International Pharmaceutical Industry and Medicine
(resident in Washington, US)
Independent: Yes

Tadataka Yamada

Dr. Tadataka Yamada was appointed to the CSL Board in September 2016. He is presently a Venture Partner at Frazier Healthcare Partners, a leading provider of growth capital to healthcare companies, a position that he has held since 2015. Prior to this, he was the Chief Medical and Scientific Officer at Takeda Pharmaceuticals, as well as a Member of the Board. Prior to Takeda, Dr. Yamada was President of the Bill & Melinda Gates Foundation Global Health Program and prior to that was Chairman of Research and Development at GlaxoSmithKline. He currently serves as a Director of Agilent Technologies, Inc. and the Clinton Health Access Initiative and a Member of the Council of the National Academy of Medicine. Dr. Yamada is also a Fellow of the Imperial College of Medicine, a Master of the American College of Physicians, a Fellow of the Royal College of Physicians.

Dr. Yamada is a member of the Innovation and Development Committee and the Nomination Committee.

Innovation

Innovation spans across our organization with a focus on solving patients' unmet needs.

Learn More
In the Community

Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.

Learn More
Recent News

Find out what's happening now at CSL.

Learn More

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter